糖尿病对经皮冠状动脉介入血管重建术后长期全因再住院的影响。

IF 2.8 4区 医学 Q3 ENDOCRINOLOGY & METABOLISM
Kirstine N Hansen, Manijeh Noori, Evald H Christiansen, Eskild B Kristiansen, Michael Maeng, Ann Dorthe O Zwisler, Britt Borregaard, Rikke Søgaard, Karsten T Veien, Anders Junker, Lisette Okkels Jensen
{"title":"糖尿病对经皮冠状动脉介入血管重建术后长期全因再住院的影响。","authors":"Kirstine N Hansen,&nbsp;Manijeh Noori,&nbsp;Evald H Christiansen,&nbsp;Eskild B Kristiansen,&nbsp;Michael Maeng,&nbsp;Ann Dorthe O Zwisler,&nbsp;Britt Borregaard,&nbsp;Rikke Søgaard,&nbsp;Karsten T Veien,&nbsp;Anders Junker,&nbsp;Lisette Okkels Jensen","doi":"10.1177/14791641221113788","DOIUrl":null,"url":null,"abstract":"<p><strong>Purpose: </strong>The purpose of the study was to investigate the incidence, cause and probability of re-hospitalization within 30 and 365 days after percutaneous coronary intervention (PCI) in patients with diabetes.</p><p><strong>Method: </strong>Between January 2010 and September 2014, 2763 patients with diabetes were treated with PCI at two Hospitals in Western Denmark. Reasons for readmission within 30 and 365 days were identified.</p><p><strong>Results: </strong>Readmission risks for patients with diabetes were 58% within 365 days and 18% within 30 days. Reason for readmission was ischemic heart disease (IHD) in 725 patients (27%), and non-IHD-related reasons in 826 patients (31%). IHD-related readmission within 365 days was associated with female gender (OR 1.3, 95% CI: 1.1-1.5), and non-ST-segment elevation myocardial infarction, compared to stable angina at the index hospitalization (OR 1.3, 95% CI: 1.1-1.6). Among patients with diabetes, increased risk of readmission due to other reasons were age (OR 1.3, 95% CI: 1.2-1.5) and higher scores of modified Charlson Comorbidity index (CCI): CCI ≥3 (OR 3.6, 95% CI: 2.8-4.6).</p><p><strong>Conclusion: </strong>More than half of the patients with diabetes mellitus undergoing PCI were readmitted within 1 year. Comorbidities were the strongest predictor for non-IHD-related readmission, but did not increase the risk for IHD-related readmissions.</p>","PeriodicalId":11092,"journal":{"name":"Diabetes & Vascular Disease Research","volume":" ","pages":"14791641221113788"},"PeriodicalIF":2.8000,"publicationDate":"2022-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/a9/79/10.1177_14791641221113788.PMC9310244.pdf","citationCount":"0","resultStr":"{\"title\":\"Impact of diabetes on long-term all-cause re-hospitalization after revascularization with percutaneous coronary intervention.\",\"authors\":\"Kirstine N Hansen,&nbsp;Manijeh Noori,&nbsp;Evald H Christiansen,&nbsp;Eskild B Kristiansen,&nbsp;Michael Maeng,&nbsp;Ann Dorthe O Zwisler,&nbsp;Britt Borregaard,&nbsp;Rikke Søgaard,&nbsp;Karsten T Veien,&nbsp;Anders Junker,&nbsp;Lisette Okkels Jensen\",\"doi\":\"10.1177/14791641221113788\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Purpose: </strong>The purpose of the study was to investigate the incidence, cause and probability of re-hospitalization within 30 and 365 days after percutaneous coronary intervention (PCI) in patients with diabetes.</p><p><strong>Method: </strong>Between January 2010 and September 2014, 2763 patients with diabetes were treated with PCI at two Hospitals in Western Denmark. Reasons for readmission within 30 and 365 days were identified.</p><p><strong>Results: </strong>Readmission risks for patients with diabetes were 58% within 365 days and 18% within 30 days. Reason for readmission was ischemic heart disease (IHD) in 725 patients (27%), and non-IHD-related reasons in 826 patients (31%). IHD-related readmission within 365 days was associated with female gender (OR 1.3, 95% CI: 1.1-1.5), and non-ST-segment elevation myocardial infarction, compared to stable angina at the index hospitalization (OR 1.3, 95% CI: 1.1-1.6). Among patients with diabetes, increased risk of readmission due to other reasons were age (OR 1.3, 95% CI: 1.2-1.5) and higher scores of modified Charlson Comorbidity index (CCI): CCI ≥3 (OR 3.6, 95% CI: 2.8-4.6).</p><p><strong>Conclusion: </strong>More than half of the patients with diabetes mellitus undergoing PCI were readmitted within 1 year. Comorbidities were the strongest predictor for non-IHD-related readmission, but did not increase the risk for IHD-related readmissions.</p>\",\"PeriodicalId\":11092,\"journal\":{\"name\":\"Diabetes & Vascular Disease Research\",\"volume\":\" \",\"pages\":\"14791641221113788\"},\"PeriodicalIF\":2.8000,\"publicationDate\":\"2022-07-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/a9/79/10.1177_14791641221113788.PMC9310244.pdf\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Diabetes & Vascular Disease Research\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1177/14791641221113788\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"ENDOCRINOLOGY & METABOLISM\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Diabetes & Vascular Disease Research","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1177/14791641221113788","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}
引用次数: 0

摘要

目的:研究糖尿病患者经皮冠状动脉介入治疗(PCI)后30天和365天内再次住院的发生率、原因和概率。方法:2010年1月至2014年9月,在丹麦西部两家医院对2763例糖尿病患者行PCI治疗。在30天和365天内确定了重新入院的原因。结果:糖尿病患者365天内再入院风险为58%,30天内再入院风险为18%。再入院原因为缺血性心脏病(IHD) 725例(27%),非缺血性心脏病相关原因826例(31%)。与指数住院时的稳定性心绞痛相比,365天内ihd相关的再入院与女性(OR 1.3, 95% CI: 1.1-1.5)和非st段抬高型心肌梗死相关(OR 1.3, 95% CI: 1.1-1.6)。在糖尿病患者中,由于年龄(OR 1.3, 95% CI: 1.2-1.5)和改良Charlson合并症指数(CCI)得分较高导致再入院风险增加:CCI≥3 (OR 3.6, 95% CI: 2.8-4.6)。结论:接受PCI治疗的糖尿病患者有一半以上在1年内再次住院。合并症是非ihd相关再入院的最强预测因子,但不会增加ihd相关再入院的风险。
本文章由计算机程序翻译,如有差异,请以英文原文为准。

Impact of diabetes on long-term all-cause re-hospitalization after revascularization with percutaneous coronary intervention.

Impact of diabetes on long-term all-cause re-hospitalization after revascularization with percutaneous coronary intervention.

Impact of diabetes on long-term all-cause re-hospitalization after revascularization with percutaneous coronary intervention.

Impact of diabetes on long-term all-cause re-hospitalization after revascularization with percutaneous coronary intervention.

Purpose: The purpose of the study was to investigate the incidence, cause and probability of re-hospitalization within 30 and 365 days after percutaneous coronary intervention (PCI) in patients with diabetes.

Method: Between January 2010 and September 2014, 2763 patients with diabetes were treated with PCI at two Hospitals in Western Denmark. Reasons for readmission within 30 and 365 days were identified.

Results: Readmission risks for patients with diabetes were 58% within 365 days and 18% within 30 days. Reason for readmission was ischemic heart disease (IHD) in 725 patients (27%), and non-IHD-related reasons in 826 patients (31%). IHD-related readmission within 365 days was associated with female gender (OR 1.3, 95% CI: 1.1-1.5), and non-ST-segment elevation myocardial infarction, compared to stable angina at the index hospitalization (OR 1.3, 95% CI: 1.1-1.6). Among patients with diabetes, increased risk of readmission due to other reasons were age (OR 1.3, 95% CI: 1.2-1.5) and higher scores of modified Charlson Comorbidity index (CCI): CCI ≥3 (OR 3.6, 95% CI: 2.8-4.6).

Conclusion: More than half of the patients with diabetes mellitus undergoing PCI were readmitted within 1 year. Comorbidities were the strongest predictor for non-IHD-related readmission, but did not increase the risk for IHD-related readmissions.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Diabetes & Vascular Disease Research
Diabetes & Vascular Disease Research ENDOCRINOLOGY & METABOLISM-PERIPHERAL VASCULAR DISEASE
CiteScore
4.40
自引率
0.00%
发文量
33
审稿时长
>12 weeks
期刊介绍: Diabetes & Vascular Disease Research is the first international peer-reviewed journal to unite diabetes and vascular disease in a single title. The journal publishes original papers, research letters and reviews. This journal is a member of the Committee on Publication Ethics (COPE)
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信